Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12605000734662
Ethics application status
Approved
Date submitted
12/09/2005
Date registered
11/11/2005
Date last updated
11/11/2005
Type of registration
Retrospectively registered

Titles & IDs
Public title
Genotypoing and data collection for the natural cystic fibrosis registry
Scientific title
Genotyping and data collection for the natural cystic fibrosis registry
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Cystic fibrosis 886 0
Condition category
Condition code
Human Genetics and Inherited Disorders 954 954 0 0
Cystic fibrosis

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Use of demographic data to assess effectiveness of treatments and service performance over an indefinite period
Intervention code [1] 528 0
None
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 1254 0
Survival
Timepoint [1] 1254 0
Secondary outcome [1] 2285 0
Lung Function
Timepoint [1] 2285 0
Secondary outcome [2] 2286 0
Nutritional status
Timepoint [2] 2286 0

Eligibility
Key inclusion criteria
All adult patients with cystic fibrosis.
Minimum age
Not stated
Maximum age
Not stated
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
No exclusion criteria

Study design
Purpose
Natural history
Duration
Longitudinal
Selection
Defined population
Timing
Both
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
1/01/1996
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
0
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 1052 0
Charities/Societies/Foundations
Name [1] 1052 0
Australian Cystic Fibrosis Trust
Country [1] 1052 0
Australia
Primary sponsor type
Charities/Societies/Foundations
Name
Australian Cystic Fibrosis Trust
Address
Country
Australia
Secondary sponsor category [1] 913 0
None
Name [1] 913 0
n/a
Address [1] 913 0
Country [1] 913 0

Ethics approval
Ethics application status
Approved

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 36006 0
Address 36006 0
Country 36006 0
Phone 36006 0
Fax 36006 0
Email 36006 0
Contact person for public queries
Name 9717 0
Associate Professor John Wilson
Address 9717 0
Cystic Fibrosis Service
The Alfred Hospital
Prahran VIC 3181
Country 9717 0
Australia
Phone 9717 0
+61 3 92763600
Fax 9717 0
+61 3 92763501
Email 9717 0
john.wilson@med.monash.edu.au
Contact person for scientific queries
Name 645 0
Associate Professor John Wilson
Address 645 0
Cystic Fibrosis Service
The Alfred Hospital
Prahran VIC 3181
Country 645 0
Australia
Phone 645 0
+61 3 92763600
Fax 645 0
+61 3 92763501
Email 645 0
john.wilson@med.monash.edu.au

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.